A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety - A review

Carbohydrate Polymers

Volumn 106, Issue 1, 2014, Pages 148-153

  Ingle, Rahul G ^a   Agarwal, Aayush S ^a  

^a Roselabs Bioscience Ltd   (India)

Author keywords

Depolymerization; Enoxaparin; Heparin; LMWHs; Pre filled syringe

Indexed keywords

DEPOLYMERIZATION; DRUG INTERACTIONS; HEALTH CARE; MOLECULAR WEIGHT; SYRINGES;

ADVERSE DRUG REACTIONS; ENOXAPARIN; FREEZING/THAWING PROCESS; HEALTH CARE PROFESSIONALS; HEPARIN; LMWHS; LOW MOLECULAR WEIGHT HEPARIN (LMWHS); PRE-FILLED SYRINGE;

POLYSACCHARIDES;

ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLOOD CLOTTING; DRUG EFFECTS; HUMAN;

ANTICOAGULANTS; BLOOD COAGULATION; ENOXAPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS;

EID: 84896288532     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.01.100     Document Type: Review

References (27)

1. O. Achour, N. Bridian, and A. Godhbani Ultrasonic assisted preparation of LMWH with anticoagulant activity Carbohydrate Polymers 2013 684 689
2. T.W. Barrowcliffe Low molecular weight heparins Journal of Hematology 1995 1 7
3. L.R. Berry, N. Parmar, M.W. Hatton, and A.K. Chan Selective cleavage of heparin using aqueous 2-hydroxypyridine: Production of an aldose-terminating fragment with high anticoagulant activity Biochemical and Biophysical Research Communication 2006 946 957
4. Branellee, J.F., Espego, J., & Picart, P. (1997). Patent No. 5599801. United States of America.
5. Debrie, R. (2005). Patent No. RE3873E. United States of America.
6. B. Detournay, X. Huet, F. Fragnani, and G. Montalescot Economic evaluation of enoxaparin sodium versus heparin in unstable angina Pharmacoeconomics 2000 83 89
7. C.E. Donayre Current use of low molecular weight heparins Seminars in Vascular Surgery 1996 362 371 (Pubitemid 26412470)
8. Enoxaparin. (2013, November). Retrieved November 2013, from Alibaba: http://www.alibaba.com.
9. European Pharmacopeia Commission European Pharmacopoeia 1991 161 165
10. Fussi, F. (1981). Patent No. 4281108. United States of America.
11. D. Green, and J. Hirsh Low molecular weight heparins: A critical analysis of clinical trials Pharmacological Reviews 1994 89 110
12. K. Higashi, S. Hosoyama, and A. Ohno Photochemical preparation of novel LMWH Carbohydrate Polymers 2012 1737 1743
13. C. Houiste, C. Auguste, C. Macrez, S. Dereux, A. Derouet, and P. Anger Quantitative PCR and disachharide profiling to characterize the animal origin of low-molecular weight heparins Clinical and Applied Thrombosis/Hemostasis 2009 50 58
14. O. Intes, J.H. Renault, C. Singuin, M.Z. Hanrot, and J.M. Nuzillard Fractionation of low molecular mass heparin by centrifugal partition chromatography in the ion exchange displacement mode Journal of Chromatography A 2001 47 57 (Pubitemid 32411442)
15. J. Jezek, N.J. Darton, B.K. Derham, N. Royle, and I. Simpson Biopharmaceutical formulations for pre-filled delivery devices Expert opinion on Drug Delivery 2013
16. S. Lai, and B. Coppola Use of enoxaparin in end-stage renal disease Kidney International 2013 433 436
17. M.A. Lima, E.H. De Farias, T.R. Rudd, L.F. Ebner, and T.F. Gesteira Low molecular weight heparins: Structural differetiation by spectroscopic and multivariate approaches Carbohydrate Polymers 2011 903 909
18. R.J. Linhardt, and N.S. Gunay Production and chemical processing of LMWHs Seminars in Thrombosis and Hemostasis 1999 25
19. L.A. Linkins, J.A. Julian, J. Rischke, J. Hirsh, and J.I. Weitz In vitro comparision of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation Thrombosis Research 2002 241 244 (Pubitemid 35435383)
20. MCCULL Pharma Nantong INC. (2012). Patent No. CN102585038A. China.
21. T. Nomura, M. Takahashi, K. Iwasaki, T. Oribe, and M. Shinohara Efficacy and safety of enoxaparin for preventing venous thromboembolic events following urologic laparoscopic surgery ISRN Urology 2013
22. C. Papageorgiou, P. Vandreden, E. Marret, F. Bonnet, and F. Robert Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagubility in patients with localized primary lung adenocarcinoma Thrombosis Research 2013, August 584 591
23. R.P. Patel, C. Narkowicz, and G.A. Jacobson Investigation of freezing- and thawing-induced biological, chemical, and physical changes to enoxaparin solution Journal of Pharmaceutical Sciences 2009 1118 1128
24. T. Seidl, and H.H. Trouillier Are 55 cents always better value than 90 cents for venous thromboembolism prophylaxis? Comparison of three low-molecular weight heparins with regard to economics and guidelines compliance Zeitschrift für Orthopädie und Unfallchirurgie 2013, October 520 524
25. C. Viskov, E. Bouley, P. Hubert, C. Martinez, F. Herman, and W. Jeske Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular weight heparin Clinical and Applied Thrombosis/Hemostasis 2009 395 401
26. Yulong, S. (2012). Patent No. CN102040673B. China.
27. Q. Zhang, X. Chen, Z. Zhu, X. Zhan, Y. Wu, and L. Song et al. Structural analysis of low molecular weight heparin by ultraperformance size exclusion chromatography/time-of-flight-mass spectrometry and capillary zone electrophoresis Analytical Chemistry 85 2013 1819 1827